ImmunityBio, Inc.'s Anktiva shows promise for solid tumors, with growing sales and financing boosting growth potential. Click ...

ImmunityBio IBRX shares rallied 27.2% on Thursday after it announced that it has completed the regulatory filing process in ...

Stock futures edged higher on Friday morning, following an eventful week marked by strong bank earnings and a slew of mixed economic data. Here are some of Frid ...